Market revenue in 2023 | USD 127.3 million |
Market revenue in 2030 | USD 155.3 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Rapid Testing Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.14% in 2023. Horizon Databook has segmented the Brazil drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of drug abuse in Brazil is anticipated to be a major factor boosting the demand for testing in the region. To fulfill the growing demand for drug testing, several key players operating in the market are entering the Brazil drug testing market by implementing organic and inorganic growth strategies.
In September 2019, Psychemedics Corporation entered into a new distribution agreement with Toxicologia Pardini Ltda. and Sansão Holding S.A. in Brazil. As per the new contract, Toxicologia Pardini and Sansao were designated as distributors of Psychemedics’ hair drug testing services in Brazil.
Furthermore, in October 2019, Omega Laboratories obtained DENATRAN accreditation for its São Paulo facility, Omega Global Laboratory Services Do Brazil. With this initiative, the company expanded its operations in Brazil. In addition, preventive policies introduced by the government are expected to have a positive impact on the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil drug testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account